Volume 20, Number 3—March 2014
Research
Hendra Virus Vaccine, a One Health Approach to Protecting Horse, Human, and Environmental Health
Table 2
Horse no., sample | log10 relative copy number of Hendra virus N RNA, dpc |
|||||||||
---|---|---|---|---|---|---|---|---|---|---|
0 | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | |
1† | ||||||||||
Blood | − | − | − | − | − | −0.2 | 1.4 | 1.7 | ||
Urine | − | − | − | − | − | − | −0.8 | 1.1 | ||
Feces | − | − | − | − | − | − | − | −0.7 | ||
Nasal swab | − | − | −0.3 | −0.2 | 1.4 | 1.6 | 1.4 | 1.7 | ||
Oral swab |
− |
− |
− |
− |
− |
−0.1 |
1.3 |
1.3 |
||
2‡ | ||||||||||
Blood | − | − | − | − | 0.5 | 2.6 | 3.0 | |||
Urine | − | − | − | − | − | 0.3 | 1.7 | |||
Feces | − | − | − | − | − | −0.05 | 2.0 | |||
Nasal swab | − | − | 1.2 | 2.0 | 1.6 | 3.5 | 2.5 | |||
Oral swab |
− |
− |
− |
− |
− |
0.4 |
1.5 |
|||
3‡ | ||||||||||
Blood | − | − | − | − | − | − | 1.5 | 2.8 | 2.9 | 3.4 |
Urine | − | − | − | − | − | − | − | 1.8 | 1.7 | 3.0 |
Feces | − | − | − | − | − | − | − | 1.5 | 1.7 | 2.1 |
Nasal swab | − | − | 1.7 | 2.5 | 1.2 | 2.4 | 3.0 | 3.8 | 3.7 | 2.0 |
Oral swab |
− |
− |
− |
− |
− |
− |
− |
1.9 |
1.9 |
2.3 |
4‡ | ||||||||||
Blood | − | − | − | − | − | 0.1 | 1.9 | 2.5 | 3.0 | |
Urine | − | − | − | − | − | − | 0.07 | 0.5 | 2.1 | |
Feces | − | − | − | − | − | − | 1.3 | 2.4 | 2.1 | |
Nasal swab | − | − | 0.3 | − | − | − | − | 1.6 | 2.5 | |
Oral swab | − | − | − | − | − | − | 0.2 | 1.2 | 1.6 |
*Duplicate samples were obtained and tested by reverse transcription PCR. Cycle threshold values were converted to relative copy numbers by using a standard curve of a sample with a known copy number. dpc, days after challenge. − indicates a negative result; blank space indicates no sample was tested.
†N gene data for horse 1 was obtained from the current study.
‡N gene data for horses 2–4 are unpublished data from a previous study (6).
References
- Halpin K, Hyatt AD, Fogarty R, Middleton D, Bingham J, Epstein JH, Pteropid bats are confirmed as the reservoir hosts of henipaviruses: a comprehensive experimental study of virus transmission. Am J Trop Med Hyg. 2011;85:946–51. DOIPubMedGoogle Scholar
- Playford EG, McCall B, Smith G, Slinko V, Allen G, Smith I, Human Hendra virus encephalitis associated with equine outbreak, Australia, 2008. Emerg Infect Dis. 2010;16:219–23. DOIPubMedGoogle Scholar
- Field H, Crameri G, Kung NY, Wang LF. Ecological aspects of Hendra virus. Curr Top Microbiol Immunol. 2012;359:11–23 . DOIPubMedGoogle Scholar
- Williamson MM, Hooper PT, Selleck PW, Gleeson LJ, Daniels PW, Westbury HA, Transmission studies of Hendra virus (equine morbillivirus) in fruit bats, horses and cats. Aust Vet J. 1998;76:813–8 . DOIPubMedGoogle Scholar
- Weingartl HM, Berhane Y, Czub M. Animal models of henipavirus infection. Vet J. 2009;181:211–20 . DOIPubMedGoogle Scholar
- Marsh GA, Haining J, Hancock TJ, Robinson R, Foord AJ, Barr JA, Experimental infection of horses with Hendra virus/Australia/Horse/2008/Redlands. Emerg Infect Dis. 2011;17:2232–8 . DOIPubMedGoogle Scholar
- Middleton DJ, Weingartl HM. Henipaviruses in their natural hosts. Curr Top Microbiol Immunol. 2012;359:105–21. DOIPubMedGoogle Scholar
- Degeling C, Kerridge I. Hendra in the news: public policy meets public morality in times of zoonotic uncertainty. Soc Sci Med. 2013;82:156–63. DOIPubMedGoogle Scholar
- Mendez DH, Judd J, Speare R. Unexpected result of Hendra virus outbreaks for veterinarians, Queensland, Australia. Emerg Infect Dis. 2012;18:83–5. DOIPubMedGoogle Scholar
- Mahalingam S, Herrero LJ, Playford EG, Spann K, Herring B, Rolph MS, Hendra virus: an emerging paramyxovirus in Australia. Lancet Infect Dis. 2012;12:799–807. DOIPubMedGoogle Scholar
- Jones KE, Patel NG, Levy MA, Storeygard A, Balk D, Gittleman J, Global trends in emerging infectious diseases. Nature. 2008;451:990–3. DOIPubMedGoogle Scholar
- Mazet JA, Clifford DL, Coppolillo PB, Deolalikar AB, Erickson JD, Kazwala RR. “One Health” approach to address emerging zoonoses: the Hali Project in Tanzania. PLoS Med. 2009;6:e1000190. DOIPubMedGoogle Scholar
- Abraham G, Muschialli J, Middleton D. Animal experimentation in level 4 facilities. In: Richmond JY, editor. Anthology of biosafety: BSL-4 laboratories. Mundelein (IL): American Biological Safety Association; 2002. p. 343–59.
- Bossart KN, Crameri G, Dimitrov AS, Mungall BA, Feng YR, Patch JR, Receptor binding, fusion inhibition and induction of cross-reactive neutralizing antibodies by a soluble G glycoprotein of Hendra virus. J Virol. 2005;79:6690–702. DOIPubMedGoogle Scholar
- Pallister J, Middleton D, Wang LF, Klein R, Haining J, Robinson R, A recombinant Hendra virus G glycoprotein–based subunit vaccine protects ferrets from lethal Hendra virus challenge. Vaccine. 2011;29:5623–30. DOIPubMedGoogle Scholar
- Mungall BA, Middleton D, Crameri G, Bingham J, Halpin K, Russell G, Feline model of acute Nipah virus infection and protection with a soluble glycoprotein-based subunit vaccine. J Virol. 2006;80:12293–302. DOIPubMedGoogle Scholar
- McEachern JA, Bingham J, Crameri G, Green DJ, Hancock TJ, Middleton D, A recombinant subunit vaccine formulation protects against lethal Nipah virus challenge in cats. Vaccine. 2008;26:3842–52. DOIPubMedGoogle Scholar
- Bossart KN, Rockx B, Feldmann F, Brining D, Scott D, LaCasse R, A Hendra virus G glycoprotein subunit vaccine protects African green monkeys from Nipah virus challenge. Sci Transl Med. 2012;4:146ra07. PMID: 22875827
- Steffen DL, Xu K, Nikolov DB, Broder CC. Henipavirus mediated membrane fusion, virus entry and targeted therapeutics. Viruses. 2012;4:280–308. DOIPubMedGoogle Scholar
- Broder C, Geisbert T, Xu K, Nikolov D, Wang L-F, Middleton D, Immunization strategies against henipaviruses. In: Lee B, Rota PA, editors. Henipavirus. Berlin: Springer; 2012. p. 197–223.
- Bossart KN, Zhu Z, Middleton D, Klippel J, Crameri G, Bingham J, A neutralizing human monoclonal antibody protects against lethal disease in a new ferret model of acute Nipah virus infection. PLoS Pathog. 2009;5:e1000642. DOIPubMedGoogle Scholar
- Bossart KN, Geisbert TW, Feldmann H, Zhu Z, Feldmann F, Geisbert JB, A neutralizing human monoclonal antibody protects African green monkeys from Hendra virus challenge. Sci Transl Med. 2011;3:105ra3. PMID: 22013123
- Guillaume V, Contamin H, Loth P, Georges-Courbot MC, Lefeuvre A, Marianneau P, Nipah virus: vaccination and passive protection studies in a hamster model. J Virol. 2004;78:834–40. DOIPubMedGoogle Scholar
- Guillaume V, Contamin H, Loth P, Grosjean I, Courbot MC, Deubel V, Antibody prophylaxis and therapy against Nipah virus infection in hamsters. J Virol. 2006;80:1972–8. DOIPubMedGoogle Scholar
- Guillaume V, Wong KT, Looi RY, Georges-Courbot MC, Barrot L, Buckland R, Acute Hendra virus infection: analysis of the pathogenesis and passive antibody protection in the hamster model. Virology. 2009;387:459–65. DOIPubMedGoogle Scholar
- Graham BS, Crowe JE. Immunization against viral diseases. In: Knipe DM, Griffin DE, Lamb RA, Straus SE, Howley PM, Martin MA, et al., editors. Fields virology. 5th ed. Philadelphia: Lippincott Williams & Wilkins; 2007. p. 487–538.
- Wolinsky JS, Waxham MN, Server AC. Protective effects of glycoprotein-specific monoclonal antibodies on the course of experimental mumps virus meningoencephalitis. J Virol. 1985;53:727–34 .PubMedGoogle Scholar
- Plotkin SA. Vaccination against the major infectious diseases. C R Acad Sci III. 1999;322:943–51. DOIPubMedGoogle Scholar
- Snoy PJ. Establishing efficacy of human products using animals: the US Food and Drug Administration's “animal rule.”. Vet Pathol. 2010;47:774–8. DOIPubMedGoogle Scholar
- Breed AC, Yu M, Barr JA, Crameri G, Thalmann CM, Wang LF. Prevalence of henipavirus and rubulavirus antibodies in pteropid bats, Papua New Guinea. Emerg Infect Dis. 2010;16:1997–9. DOIPubMedGoogle Scholar
- Drexler JF, Corman VM, Gloza-Rausch F, Seebens A, Annan A, Ipsen A, Henipavirus RNA in African bats. PLoS ONE. 2009;4:e6367. DOIPubMedGoogle Scholar
- Epstein JH, Prakash V, Smith CS, Daszak P, McLaughlin AB, Meehan G, Henipavirus infection in fruit bats (Pteropus giganteus), India. Emerg Infect Dis. 2008;14:1309–11. DOIPubMedGoogle Scholar
1These authors contributed equally to this article.
Page created: February 19, 2014
Page updated: February 19, 2014
Page reviewed: February 19, 2014
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.